Results 11 to 20 of about 6,757 (189)

Conventional type 1 dendritic cells (cDC1) in cancer immunity

open access: yesBiology Direct, 2023
Cancer immunotherapy, alone or in combination with conventional therapies, has revolutionized the landscape of antineoplastic treatments, with dendritic cells (DC) emerging as key orchestrators of anti-tumor immune responses.
Peng Liu   +3 more
doaj   +4 more sources

cDC1 dysregulation in cancer: An opportunity for intervention [PDF]

open access: yesJournal of Experimental Medicine, 2020
Conventional dendritic cells driven by the transcription factor Batf3 (cDC1 cells) are critical for the activation and maintenance of tumor-specific CD8+ T cells. In this issue of JEM, Lin et al. (https://doi.org/10.1084/jem.20190673) demonstrate systemic dysfunction of cDC1 cells in pancreatic cancer, which offers potential treatment strategies to ...
Thomas F. Gajewski, Kyle R. Cron
openaire   +2 more sources

Type 1 conventional dendritic cells and interferons are required for spontaneous CD4+ and CD8+ T‐cell protective responses to breast cancer

open access: yesClinical & Translational Immunology, 2021
Objectives To better understand how immune responses may be harnessed against breast cancer, we investigated which immune cell types and signalling pathways are required for spontaneous control of a mouse model of mammary adenocarcinoma.
Raphaël Mattiuz   +11 more
doaj   +1 more source

The transcription factor Zeb1 controls homeostasis and function of type 1 conventional dendritic cells

open access: yesNature Communications, 2023
Type 1 conventional dendritic cells (cDC1) are the most efficient cross-presenting cells that induce protective cytotoxic T cell response. However, the regulation of their homeostasis and function is incompletely understood.
Yan Wang   +18 more
doaj   +1 more source

STAT3 signaling modulates the immune response induced after antigen targeting to conventional type 1 dendritic cells through the DEC205 receptor

open access: yesFrontiers in Immunology, 2022
Conventional dendritic cells (cDC) are a group of antigen-presenting cells specialized in priming T cell responses. In mice, splenic cDC are divided into conventional type 1 DC (cDC1) and conventional type 2 (cDC2).
Fernando Bandeira Sulczewski   +7 more
doaj   +1 more source

Priority lane to cDC1 open for IRF8+ progenitors [PDF]

open access: yesBlood, 2019
In this issue of Blood , Kurotaki et al demonstrate that IRF8 expression delineates a subset of lymphoid-primed multipotent progenitors (LMPPs) biased toward the generation of conventional type 1 dendritic cells (cDC1s) by epigenetically priming the precursors for the expression of dendritic cell (DC) lineage genes ...
Martin Guilliams, Charlotte L. Scott
openaire   +2 more sources

Direct Reprogramming of Mouse Embryonic Fibroblasts to Conventional Type 1 Dendritic Cells by Enforced Expression of Transcription Factors

open access: yesBio-Protocol, 2020
Ectopic expression of transcription factor combinations has been recently demonstrated to reprogram differentiated somatic cells towards the dendritic cell (DC) lineage without reversion to a multipotent state.
Fábio Rosa   +3 more
doaj   +1 more source

cDC1 are required for the initiation of collagen-induced arthritis

open access: yesJournal of Translational Autoimmunity, 2020
Rheumatoid arthritis (RA) is chronic autoimmune disease which etiology remains unknown. Several cell types have been described to potentiate/aggravate the arthritic process however the initiating event in synovial inflammation is still elusive. Dendritic cells (DCs) are essential for the initiation of primary immune responses and thus we hypothesized ...
Ramos, Maria Ines   +7 more
openaire   +4 more sources

SMRT and NCoR1 fine-tune inflammatory versus tolerogenic balance in dendritic cells by differentially regulating STAT3 signaling

open access: yesFrontiers in Immunology, 2022
Dendritic cell (DC) fine-tunes inflammatory versus tolerogenic responses to protect from immune-pathology. However, the role of co-regulators in maintaining this balance is unexplored.
Atimukta Jha   +18 more
doaj   +1 more source

Data from cDC1 Vaccines Drive Tumor Rejection by Direct Presentation Independently of Host cDC1

open access: yes, 2023
<div>Abstract<p>As a cell-based cancer vaccine, dendritic cells (DC), derived from peripheral blood monocytes or bone marrow (BM) treated with GM-CSF (GMDC), were initially thought to induce antitumor immunity by presenting tumor antigens directly to host T cells.
Kenneth M. Murphy   +10 more
openaire   +1 more source

Home - About - Disclaimer - Privacy